Ikena Oncology Ownership | Who Owns Ikena Oncology?

Overview Forecast RevenueFinancials Chart

Ikena Oncology Ownership Summary

Ikena Oncology is owned by 58.87% institutional investors, 10.50% insiders, and 30.64% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 10.40% of IKNA shares. Worldwide Healthcare Ord is the top mutual fund, with 3.37% of its assets in Ikena Oncology shares.

IKNA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ikena Oncology	58.87%	10.50%	30.64%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Atlas venture life science advisors	5.02M	10.40%	$8.28M
Bvf inc/il	4.77M	9.88%	$7.87M
Blue owl capital lp	4.09M	8.48%	$6.75M
Orbimed advisors	3.54M	7.33%	$5.84M
Omega fund management	2.25M	4.66%	$3.71M
Vanguard group	1.36M	2.83%	$2.25M
Adage capital partners gp	987.90K	2.05%	$1.63M
Bml capital management	585.11K	1.21%	$965.44K
Nea management company	570.05K	1.18%	$940.58K
Renaissance	476.40K	0.99%	$786.06K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Omega fund management	2.25M	2.75%	$3.71M
Blue owl capital lp	4.09M	1.88%	$6.75M
Atlas venture life science advisors	5.02M	0.87%	$8.28M
Bml capital management	585.11K	0.69%	$965.44K
Acuitas investments	399.88K	0.35%	$659.80K
Deuterium capital management	80.58K	0.22%	$132.95K
Bvf inc/il	4.77M	0.22%	$7.87M
Orbimed advisors	3.54M	0.12%	$5.84M
Nea management company	570.05K	0.07%	$940.58K
Sofinnova investments	382.62K	0.03%	$631.32K

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	987.90K	0.00%	700.00K
Bml capital management	585.11K	0.69%	585.11K
Millennium management	354.71K	0.00%	354.71K
Goldman sachs group	273.83K	0.00%	201.24K
Blue owl capital lp	4.09M	1.88%	200.00K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	354.84K	-	-1.47M
State street	80.35K	-	-402.29K
Geode capital management	256.71K	-	-340.57K
Renaissance	476.40K	0.00%	-300.20K
Vanguard group	1.36M	-	-167.70K

New Positions

Holder	Shares	% Assets	Change	Value
Bml capital management	585.11K	0.69%	585.11K	$965.44K
Millennium management	354.71K	0.00%	354.71K	$585.27K
Deuterium capital management	80.58K	0.22%	80.58K	$132.95K
Jbf capital	72.65K	0.02%	72.65K	$119.87K
Point72 asia (singapore) pte.	45.52K	0.02%	45.52K	$75.11K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-3.00
Royal bank of canada	-707.00
Amalgamated bank	-717.00
Cwm	-985.00
Ameritas investment partners	-1.75K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	57	-16.18%	28,407,567	-2.06%	58	1.63%	19	-53.66%	19	5.56%
Jun 30, 2024	68	21.43%	29,003,651	-3.64%	60	1.16%	41	57.69%	18	5.88%
Mar 31, 2024	56	3.70%	30,097,828	-7.07%	72	1.30%	26	-23.53%	17	41.67%
Dec 31, 2023	54	-6.90%	32,386,521	-0.99%	74	1.08%	34	-	12	33.33%
Sep 30, 2023	58	11.54%	32,711,737	4.85%	83	1.12%	34	-5.56%	9	28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Worldwide Healthcare Ord	1.63M	3.37%	-
Vanguard Total Stock Mkt Idx Inv	1.05M	2.18%	-
Vanguard Institutional Extnd Mkt Idx Tr	318.15K	0.66%	-
Fidelity Extended Market Index	137.43K	0.28%	7.20K
Bridgeway Ultra-Small Company Market	100.00K	0.21%	25.00K
NT R2000 Value Index Fund - NL	87.83K	0.18%	18.26K
NT R2000 Index Fund - NL	77.70K	0.16%	-9.21K
Northern Trust Russell 2000 Value Index	64.58K	0.13%	855.00
NT R2000 Value Index Fund - L	64.58K	0.13%	855.00
iShares Micro-Cap ETF	62.75K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 24, 2022	ORBIMED ADVISORS LLC	-	Sell	$288.27K
Jun 23, 2022	ORBIMED ADVISORS LLC	-	Sell	$86.88K
Jun 22, 2022	ORBIMED ADVISORS LLC	-	Sell	$237.16K
Jun 22, 2022	OrbiMed Genesis GP LLC		Sell	$237.16K
Jun 24, 2022	ORBIMED ADVISORS LLC	-	Sell	$515.71K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	-	-
2023 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-
2022 Q4	-	-

IKNA Ownership FAQ

Who Owns Ikena Oncology?

Ikena Oncology shareholders are primarily institutional investors at 58.87%, followed by 10.50% insiders and 30.63% retail investors. The average institutional ownership in Ikena Oncology's industry, Biotech Stocks , is 47.04%, which Ikena Oncology exceeds.

Who owns the most shares of Ikena Oncology?

Ikena Oncology’s largest shareholders are Atlas venture life science advisors (5.02M shares, 10.40%), Bvf inc/il (4.77M shares, 9.88%), and Blue owl capital lp (4.09M shares, 8.48%). Together, they hold 28.76% of Ikena Oncology’s total shares outstanding.

Does Blackrock own Ikena Oncology?

BlackRock is not among the top 10 institutional shareholders of Ikena Oncology.

Who is Ikena Oncology’s biggest shareholder by percentage of total assets invested?

Omega fund management is Ikena Oncology’s biggest shareholder by percentage of total assets invested, with 2.75% of its assets in 2.25M Ikena Oncology shares, valued at 3.71M$.

Who is the top mutual fund holder of Ikena Oncology shares?

Worldwide Healthcare Ord is the top mutual fund holder of Ikena Oncology shares, with 3.37% of its total shares outstanding invested in 1.63M Ikena Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools